Antacids linked to higher risk of c. diff, study finds

Share this article:
Use of proton pump inhibitors, which have medications used to suppress stomach acid, can increase the risk of Clostridium difficile infections, especially when combined with antibiotics, a new study finds.

Investigators analyzed data from 42 observational studies with a total of 313,000 participants. Data from 39 of those studies showed that use of PPIs, which includes medications such as Prilosec and Nexium, was linked to a significantly higher risk of c. diff, and three studies showed a higher risk of recurrent infections with PPIs. Additionally, concurrent use of PPIs and antibiotics had an even higher risk for c. diff, according to the study.

C. diff is characterized by severe diarrhea and can be deadly in elderly nursing home residents.

"For patients who have suffered C. difficile diarrhea, we recommend that they come off the PPIs either temporarily or even permanently so that there is less chance of the diarrhea coming back," Norwich Medical School's Yoon Kong Loke, M.D., told Reuters.

The study was published recently in The American Journal of Gastroenterology.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...